# An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)

> **NCT06838845** · — · RECRUITING · sponsor: **AbbVie** · enrollment: 80 (estimated)

## Conditions studied

- Ulcerative Colitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06838845
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-09
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06838845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06838845, "An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06838845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*